Package 62135-676-30

Brand: rasagiline

Generic: rasagiline
NDC Package

Package Facts

Identity

Package NDC 62135-676-30
Digits Only 6213567630
Product NDC 62135-676
Product ID 62135-676_17dd92b2-969b-16f1-e063-6394a90aee89
Description

30 TABLET in 1 BOTTLE (62135-676-30)

Marketing

Marketing Status
Marketed Since 2024-05-01
Brand rasagiline
Generic rasagiline
Sample Package No

Linked Drug Pages (1)

Rasagiline ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "17dd92b2-969b-16f1-e063-6394a90aee89", "openfda": {"upc": ["0362135677305", "0362135676308"], "unii": ["LH8C2JI290"], "rxcui": ["608328", "636664"], "spl_set_id": ["d9168d62-814a-444f-9d70-11674def339d"], "manufacturer_name": ["Chartwell RX, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (62135-676-30)", "package_ndc": "62135-676-30", "marketing_start_date": "20240501"}], "brand_name": "Rasagiline", "product_id": "62135-676_17dd92b2-969b-16f1-e063-6394a90aee89", "dosage_form": "TABLET", "pharm_class": ["Monoamine Oxidase Inhibitor [EPC]", "Monoamine Oxidase Inhibitors [MoA]"], "product_ndc": "62135-676", "generic_name": "Rasagiline", "labeler_name": "Chartwell RX, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Rasagiline", "active_ingredients": [{"name": "RASAGILINE MESYLATE", "strength": ".5 mg/1"}], "application_number": "ANDA201892", "marketing_category": "ANDA", "marketing_start_date": "20180727", "listing_expiration_date": "20261231"}